Noah L. Rosenberg

Insider Reports History

Location
C/O Esperion Therapeutics, Inc., 46701 Commerce Center Drive, Plymouth, MI
Signature
/s/ Christopher Hayes, Attormey-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Noah L. Rosenberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Travere Therapeutics, Inc. Chief Medical Officer Common Stock 47.6K $427K $8.96 Aug 17, 2021 Direct
Verrica Pharmaceuticals Inc. CMO Employee Stock Option (right to buy) 325K Mar 24, 2025 Direct

Insider Reports Filed by Noah L. Rosenberg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRCA Verrica Pharmaceuticals Inc. Mar 24, 2025 1 $0 4 Mar 26, 2025 CMO
VRCA Verrica Pharmaceuticals Inc. Mar 24, 2025 0 $0 3 Mar 26, 2025 CMO
TVTX Travere Therapeutics, Inc. Aug 13, 2021 2 -$24.1K 4 Aug 17, 2021 Chief Medical Officer
TVTX Travere Therapeutics, Inc. Jul 28, 2021 1 -$17.3K 4 Jul 29, 2021 Chief Medical Officer
TVTX Travere Therapeutics, Inc. May 11, 2021 2 -$14.5K 4 May 13, 2021 Chief Medical Officer